A bill to amend the Federal Food, Drug, and Cosmetic Act in order to impose certain restrictions on oral representations made to physicians and pharmacists regarding drugs, and to impose certain restrictions on the written advertising of drugs.

[AI summary unavailable — showing source text] Provides that no information with respect to any drug shall be given orally to any licensed practitioner or pharmacist by any employee or person representing a drug firm unless immediately prior to the time of such oral information, a copy is given of a document approved by the Secretary of Health, Education, and Welfare relating to such drug and containing such information about such drug as the Secretary may by regulation require. Provides that all drug advertisements must be approved by the Secretary under specified guidelines. Provides that all published articles intended for health professionals dealing with drugs shall, under specified regulations, identify the person or persons who provided financial support to the author for his writing or research.…